Johns Hopkins Medicine scientists say their 20-year study of more than 200 people with premature aging syndromes caused by abnormally short telomeres, or shortened repetitive DNA sequences at the ends of chromosomes, may ...
Mar 30, 2023
0
77
A new non-surgical treatment for low-risk prostate cancer can effectively kill cancer cells while preserving healthy tissue, reports a new UCL-led phase III clinical trial in 413 patients. The trial was funded by STEBA Biotech ...
Dec 19, 2016
0
222
Findings from a new study performed in mice suggest that omega-3 fatty acids could help immunotherapy and other treatments do a better job at fighting cancer. Immunotherapies, which stimulate the body's own immune system ...
Apr 1, 2022
0
17
Women who eat more high-fiber foods during adolescence and young adulthood—especially lots of fruits and vegetables—may have significantly lower breast cancer risk than those who eat less dietary fiber when young, according ...
Feb 1, 2016
0
184
Alcohol consumption caused more than 700,000 new cancer cases and around 366,000 cancer deaths in 2012, mainly in rich countries, according to data reported Wednesday to the World Cancer Congress in Paris.
Nov 2, 2016
0
3
Aspirin is associated with a reduction in the risk of developing several cancers of the digestive tract, including some that are almost invariably fatal, such as pancreatic and liver cancers.
Apr 16, 2020
0
563
Boosting physical activity levels and curbing sitting time are highly likely to lower breast cancer risk, finds research designed to strengthen proof of causation and published online in the British Journal of Sports Medicine.
Sep 6, 2022
0
95
A CAR T-cell therapy known as axicabtagene ciloleucel (axi-cel) drove cancer cells to undetectable levels in nearly 80% of patients with advanced non-Hodgkin lymphoma (NHL) in a phase 2 clinical trial, Dana-Farber Cancer ...
Dec 5, 2020
0
187
Prostate cancer is the most common cancer in men in Europe and the second most frequently diagnosed cancer in men worldwide.
Jul 14, 2017
0
9
(HealthDay)—Comorbidity burden is strongly and independently associated with pathological upgrading/up staging in men with clinically low-risk prostate cancer, according to a study published in the April issue of The Journal ...
Apr 22, 2016
0
4
